View Post

Triple negative breast cancers can adopt reversible state that is resistant to chemotherapy

In In The News by Barbara Jacoby

Source: University of Texas M. D. Anderson Cancer Center From: eurekalert.org Study finds that resistant cells become vulnerable to MD Anderson-developed targeted therapy Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on …

View Post

Targeting Innovation in Small Cell Lung Cancer

In Clinical Trials by Barbara Jacoby

By: Heather Stringer From: curetoday.com After consulting multiple doctors about her ongoing cough and congestion, LeeAnn Devore asked one of her physicians if she might have lung cancer. “He said the symptoms weren’t right,” says Devore, 66, of Magnolia, Texas. Three X-rays in five months confirmed that she had pneumonia in her right lung, yet she wasn’t responding to traditional …

View Post

First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple cancers

In In The News by Barbara Jacoby

Source: University of Texas M. D. Anderson Cancer Center From: sciencedaily.com A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising …

View Post

Potential new strategy to fight ovarian cancer found

In In The News by Barbara Jacoby

From: bcm.edu A new discovery opens the possibility of developing a novel way to fight ovarian cancer. Researchers at Baylor College of Medicine and the University of Texas MD Anderson Cancer Center have revealed a previously unknown cellular pathway that selectively regulates a mutant protein, called p53-R175H, linked to ovarian cancer growth. The researchers identified a key regulator of this …

View Post

First computer program developed to detect DNA mutations in single cancer cells

In In The News by Barbara Jacoby

Source: University of Texas M. D. Anderson Cancer Center From: sciencedaily.com Researchers at The University of Texas MD Anderson Cancer Center have announced a new method for detecting DNA mutations in a single cancer cell versus current technology that analyzes millions of cells which they believe could have important applications for cancer diagnosis and treatment. The results are published in …

View Post

Kanzius Cancer Machine Gets Its First Human Trial

In In The News by Barbara Jacoby

By: Erika Hayasaki From: newsweek.com His body ravaged by chemotherapy treatments, retired radio engineer John Kanzius spent months in his basement in 2003 cobbling together a makeshift tumor-killing machine. Kanzius had no medical background. He had been a ham radio operator and the owner of a television and radio station company. But he had leukemia, and he did not want …

Health Law Concerns for Cancer Centers

In In The News by Barbara Jacoby

By RICARDO ALONSO-ZALDIVAR Associated Press Cancer patients relieved that they can get insurance coverage because of the new health care law may be disappointed to learn that some the nation’s best cancer hospitals are off-limits. An Associated Press survey found examples coast to coast. Seattle Cancer Care Alliance is excluded by five out of eight insurers in Washington state’s insurance …

Cancer patient’s compassionate use conundrum incites a social media ambush on BioMarin

In In The News by Barbara Jacoby

by Deanna Pogorelc Posted in MedCity News For the past seven years, Andrea Sloan has been battling ovarian cancer. Now, she’s waging a second battle – this one against BioMarin Pharmaceuticals (NASDAQ:BMRN) – after being denied access to an experimental drug she thinks is her last hope. And in the process, she’s raising some tough questions about the process of …